Literature DB >> 27447111

A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR.

A Tosco, F De Gregorio, S Esposito, D De Stefano, I Sana, E Ferrari, A Sepe, L Salvadori, P Buonpensiero, A Di Pasqua, R Grassia, C A Leone, S Guido, G De Rosa, S Lusa, G Bona, G Stoll, M C Maiuri, A Mehta, G Kroemer, L Maiuri, V Raia.   

Abstract

This corrects the article DOI: 10.1038/cdd.2016.22.

Entities:  

Year:  2016        PMID： 27447111      PMCID： PMC5520161          DOI： 10.1038/cdd.2016.43

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN： 1350-9047            Impact factor:   15.828


  5 in total

1.  Silencing of the Hsp70-specific nucleotide-exchange factor BAG3 corrects the F508del-CFTR variant by restoring autophagy.

Authors:  Darren M Hutt; Sanjay Kumar Mishra; Daniela Martino Roth; Mads Breum Larsen; Frédéric Angles; Raymond A Frizzell; William E Balch
Journal:  J Biol Chem       Date:  2018-07-09       Impact factor: 5.157

Review 2.  Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives.

Authors:  Béla Z Schmidt; Jérémy B Haaf; Teresinha Leal; Sabrina Noel
Journal:  Clin Pharmacol       Date:  2016-09-21

3.  microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A4 receptor-dependent mechanisms of inflammation resolution and antimicrobial defense.

Authors:  Anna Maria Pierdomenico; Sara Patruno; Marilina Codagnone; Felice Simiele; Veronica Cecilia Mari; Roberto Plebani; Antonio Recchiuti; Mario Romano
Journal:  Sci Rep       Date:  2017-10-18       Impact factor: 4.379

4.  Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.

Authors:  Tonino Alonzi; Alessandra Aiello; Linda Petrone; Saeid Najafi Fard; Manuela D'Eletto; Laura Falasca; Roberta Nardacci; Federica Rossin; Giovanni Delogu; Concetta Castilletti; Maria Rosaria Capobianchi; Giuseppe Ippolito; Mauro Piacentini; Delia Goletti
Journal:  Cells       Date:  2021-12-24       Impact factor: 6.600

Review 5.  Transcriptomic and Proteostasis Networks of CFTR and the Development of Small Molecule Modulators for the Treatment of Cystic Fibrosis Lung Disease.

Authors:  Matthew D Strub; Paul B McCray
Journal:  Genes (Basel)       Date:  2020-05-13       Impact factor: 4.096
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.